Tanigawara Yusuke 谷川原祐介

… Alternative Names

谷川原祐介タニガワラユウスケ

TANIGAWARA Yusuke 谷川原祐介

Less

Researcher Number	30179832
Other IDs
External Links
Affiliation (Current)	2025: 慶應義塾大学, 殿町先端研究教育連携スクエア, 特任教授 2025: 慶應義塾大学, 医学部(信濃町), 講師(非常勤)
Affiliation (based on the past Project Information) *help	2016 – 2020: 慶應義塾大学, 医学部(信濃町), 教授 2000 – 2014: 慶應義塾大学, 医学部, 教授 2007: Musashino University, School of Medicine, Department of Pharmacy, Professor 1997: 神戸大学, 医学部・付属病院, 助教授 1994 – 1997: 神戸大学, 医学部・附属病院, 助教授 … More 1995 – 1996: 神戸大学, 医学部附属病院, 助教授 1993 – 1995: 神戸大学, 医学部, 助教授 1993: Kobe University Faculty of Medicine Associated Professor, 医学部, 講師 1991 – 1992: 京都大学, 医学部, 講師 1986 – 1989: Kyoto University, 医学部, 助手 Less
Review Section/Research Field	Principal Investigator Biological Sciences / 応用薬理学・医療系薬学 / Medical pharmacy / Physical pharmacy / 医薬分子機能学 Except Principal Investigator 応用薬理学・医療系薬学 / Medical pharmacy / Applied pharmacology / Respiratory organ internal medicine / Respiratory organ internal medicine … More / 応用生物化学・栄養化学 / Physical pharmacy / Applied biochemistry / Endocrinology Less
Keywords	Principal Investigator CYP3A5 / 抗がん剤 / ドセタキセル / 薬剤反応性 / 薬物代謝酵素 / Pharmacokinetics / バイオマーカー / 薬物動態 / 遺伝子診断 / TaqMan PCR法 … More / CYP2C9 / オキサリプラチン / プロテオーム / 個別化医療 / 個人差 / イリノテカン / メタボローム / 遺伝子多型 / TS-1 / Population Pharmacokinetics / CYP2C93 / CYP2D6 / TaqManPCR法 / 遺伝子変異多型 / ワルファリン / protein chip / biomarker / プロテインチップ / genotyping / S-1 / docetaxel / pharmacokinetics / Anticancer agents / Multidrug resistance / P-glycoprotein / 薬剤耐性 / PSC 833 / シクロスポリン / MDR / P糖蛋白質 / SELDI-TOF MS / 抗癌剤 / 5-FU / ゲムシタビン / 薬力学 / 薬物体内動態 / PD解析 / 一塩基変異多型 / 凝固系第VII因子 / 薬物血中濃度 / irinotecan / oxaliplatin / chemosensitivity / metabolome / proteome / personalized medecine / MALDI-MS / 薬剤感受性 / DNA microarray / small bowel transplantation / liver transplantation / cardiac transplantation / immunosuppressive agents / 拒絶反応 / コルチゾール / 6β-水酸化コルチゾール / CYP3A / シクロスポリンA / 生体肝移植 / 網羅的解析 / 拒絶反応バイオマーカー / 小腸移植モデル / 心臓移植モデル / DNAマイクロアレイ / 小腸移植 / 肝移植 / 心移植 / 免疫抑制剤 / HMG-CoA reductase inhibitor / fluvastatin / 高コレステロール血症治療 / 血栓症治療 / HMG-CoA還元酵素阻害剤 / フルバスタチン / drug metabolizing enzyme / anticancer drug / 薬物血中濃度モニタリング / CYP3A4 / CYP3A5^3 / Chemosensitizer / Transport / SDZ PSC-833 / doxorubicin / chemosensitizer / anticancer agents / transport / multidrug resistance / Clinical Pharmacology / Pharmacodynamics / Docetaxl / クリアランス / 臨床薬理学 / population pharacokinetics / 臨床薬理 / population pharmacokinetics / Doxorubicin / Reversal of resistance / Cyclosporin / トランスポーター / 薬物排泄 / 多剤耐性 / ドキソルビシン / 耐性克服 / がん治療 / オーダーメイド医療 / 核酸代謝 / SN-38 / CE-TOFMS / 腫瘍縮小効果 / PK / α_1-酸性糖タンパク質 / 非小細胞肺癌 / 下痢 / population PK / 癌 / 遺伝子 / CYP2D6*10 / タモキシフェン / 血液凝固 … More Except Principal Investigator バイオマーカー / 抗がん剤 / 癌 / 多剤耐性 / PK / 薬物体内動態 / 投与設計 / P-glycoprotein / 免疫抑制剤 / Pharmacodynamics / Pharmacokinetics / immunosuppressive drugs / 薬物動態・薬力学解析 / 拒絶反応 / 臓器移植 / UGT / CYP / カルボプラチン / PD / TDM / therapeutic drug monitoring / アミノグリコシド系抗生物質 / 薬物血中濃度モニタリング / CRP / Helicobacter pylori / CYP2C19 / ジゴキシン / population pharmacokinetics / Population pharmacokinetics / Gene transfection / ドセタキセル / オキサリプラチン / 薬剤反応性 / 個別化医療 / 薬物動態 / ステロイドホルモン / トランスポーター / 抗癌剤 / 物質輸送 / 分子生物学 / 癌遺伝子 / MDR1遺伝子 / exposure matching / 個別化投薬 / がん薬物療法 / PK規定因子 / 薬物曝露量 / 個別化投与 / 薬理学 / EGFRチロシンキナーゼ阻害剤 / 臨床薬理学 / 非小細胞肺癌 / Cisplatin / Cyclosporin / Aminoglycoside / Cultured Renal Epithelial Cell / Cell Culture / Nephrotoxicity / LLC-PK_1細胞 / シスプラチン / シクロスポリン / LLC-PK1細胞 / 培養腎上皮細胞 / 腎毒性 / Renal dysfunction / Hyperthyroidism / Arrhythmias / Disease state models / Design of dosage regimen / Antiarrhythmics / エフェクトコンパートメントモデル / 心電図 / 心拍数依存性 / 甲状腺機能亢進 / 病態 / 薬理効果 / 抗不整脈剤 / プロプラノロ-ル / アジマリン / バイオアベイラビリティ- / 初回通過効果 / 腎疾患 / 甲状腺機能亢進症 / 不整脈 / 病態モデル動物 / 薬物投与計画 / pharmacodynamics / pharmacokinetics / 抗不整脈薬 / digoxin / carbamazepine; phenytoin / valproic acid / drug dosage regimen / VALPROIC ACID / THEOPHYLLINE / THERAPEUTIC DRUG MONITORING / ベイズ理論 / POPULATION / PHARMACOKINETICS / テオフィリン / フェニトイン / カルバマゼピン / バルプロ酸 / 薬物治療モニタリング / Non-invasive / Protein Chip / Rejection / Biomarkers / Organ Transplantation / 低浸襲 / プロテインチップ / PD analysis / rejection / rat / cDNA microarray / biomarkers / organ transplantation / ラット / cDNAマイクロアレイ / dosage adjustment / determining dosage / renally excreted drug / carboplatin / teicoplanin / vancomycin / creatinin clearance / cvstatin C / バンコマイシン / 腎機能 / 血清尿素窒素 / メトトレキサート / 血清クレアチニン / 医薬品適正使用 / 腎排泄型薬物 / テイコプラニン / 塩酸バンコマイシン / クレアチニンクリアランス / シスタチンC / Docetaxel / Irinotecan Hydrochloride / Carboplatin / Paclitaxel / バクリタキセル / 塩酸イリノテカン / パクリタキセル / clinical efficacy / trough serum concentration / peak serum concentration / glycopeptide / aminoglycoside / carbapenem / MIC / 感受性試験 / 重症感染症 / 血液透析 / トブラマイシン / アミカシン / メロペネム / 治療効果 / トラフ血中濃度 / ピーク血中濃度 / 薬物血中濃度モニタリン / グリコペプチド系抗生物質 / アミノグリコシド系抗生 / カルバペネム系抗生物質 / INFLAMMATION / EX VIVO / CYTOTOXICTTY / ACTIVEOXYGEN / TRANSFORMING / IN VIVO / GENE THERAPY / SUPEROXIDE DISMUTASE / 肺 / スーパーオキシドティスムターゼ / 炎症 / ex vivo法 / 細胞障害 / 活性酸素 / 遺伝子導入 / in vivo実験 / 遺伝子治療 / スーパーオキシドディスムターゼ / omeprazole / salazosulfapyridine / procainamide / isoniazid / genotyping / N-acetyltransferase / RFLP / PCR / プロカインアミド / 多型性 / 表現型 / 遺伝子型 / N-アセチルトランスフェラーゼ / 血液 / PCR-RELP / 爪 / 口腔粘膜細胞 / 毛髪 / 除菌治療効果 / 潰瘍性大腸炎 / サラゾピリン / イソニアジド / オメプラゾール / プロカインアシド / 非血液検体 / 遺伝子タイピング / N-アセチル転移酵素 / Chemotherapy / Transporter / Cancer / MDR1 gene / Steroid hormone / Multidrug resistance / P-糖蛋白質 / Dosage regimen / Isolated perfused kidney / Renal excretion / モ-メント解析 / 刷子縁膜 / 有機アニオン輸送系 / 薬物投与設計 / gene transfection / 経細胞輸送 / 有機カチオン輸送系 / 摘出腎潅流 / 腎排泄 / S100A10 / PK/PD解析 / ｵｰﾀﾞｰﾒｲﾄﾞ医療 / 臨床 / 薬学 / がん / 非小細胞肺がん / 高齢者 / スペシャル・ポピュレーション / PK/PD 解析 / オーダーメイド医療 / フルオロウラシル / 個人差 / プロテオーム / オミックス解析 / エネルギー代謝 / 生活習慣病 / 核内受容体 / 胆汁酸 / 糖尿病 / 代謝 / ナトリウム利尿ペプチド / cGMP / ミトコンドリア / アンジオテンシン / cGMPナトリウム利尿ペプチド / NO / 心血管ホルモン / エイジング / メタボリックシンドローム / アポトーシス / 耐性克服 / シスプラチン耐性 / DNAトポイソメラーゼ / ABCカッセトファミリー / p-糖蛋白 / 薬剤耐性 / 転写制御 / MDR1 / P糖蛋白 / 癌治療 / シクロスポリンA / P糖蛋白質 / 遺伝子発現 / Pー糖蛋白質 Less

Development of individualized medicine by exposure matching based on key determinant of pharmacokinetics
- Principal Investigator
  
  IMAMURA Chiyo
- Project Period (FY)
  2017 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Applied pharmacology
- Research Institution
  Showa University
  Keio University
Therapeutic drug monitoring of EGFR-KIs for non-small cell lung cancer patients
- Principal Investigator
  
  Hirotsugu Kenmotsu
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Shizuoka Cancer Center Research Institute
Development of new candidate, newly found out by proteomic approach, as a predictive biomarker for chemotherapy
- Principal Investigator
  
  SUZUKI Sayo
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Keio University
Proteomic and metabolomic analysis on chemo-sensitivity and resistance of cancer towards personalized medicinePrincipal Investigator
- Principal Investigator
  
  TANIGAWARA Yusuke
- Project Period (FY)
  2011 – 2013
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Medical pharmacy
- Research Institution
  Keio University
Exploratory studyof dose adjustmentof oncologic drugs for special populations
- Principal Investigator
  
  IMAMURA Chiyo
- Project Period (FY)
  2010 – 2012
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Keio University
Proteomic analysis to find predictive markers for chemotherapeutic response, and basic study for biomarker development
- Principal Investigator
  
  SUZUKI Sayo
- Project Period (FY)
  2009 – 2011
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Keio University
がんのメタボローム解析に基づく抗がん剤反応性予測の新戦略Principal Investigator
- Principal Investigator
  
  谷川原祐介
- Project Period (FY)
  2008 – 2009
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas
- Review Section
  
  Biological Sciences
- Research Institution
  Keio University
Proteomic analysis for elucidation of individual differences in chemotherapeutic response and for biomarker developmentPrincipal Investigator
- Principal Investigator
  
  TANIGAWARA Yusuke
- Project Period (FY)
  2008 – 2010
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Medical pharmacy
- Research Institution
  Keio University
Approach to metabolic syndrome by analysing the energy metabolism homeostasis
- Principal Investigator
  
  WATANABE Mitsuhiro
- Project Period (FY)
  2008 – 2010
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Applied biochemistry
- Research Institution
  Keio University
Cardiovascular-endocrinological approach for elucidation of the molecular mechanism of "Metabo-aging"
- Principal Investigator
  
  ITOH Hiroshi
- Project Period (FY)
  2007 – 2008
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Endocrinology
- Research Institution
  Keio University
Proteomic approach for personalized Medicine in cancer chemotherapyPrincipal Investigator
- Principal Investigator
  
  TANIGAWARA Yusuke
- Project Period (FY)
  2006 – 2007
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Medical pharmacy
- Research Institution
  Keio University
Individualization of dosage for immunosuppressive drugs based on new biomarkers
- Principal Investigator
  
  MIHARA Kiyoshi
- Project Period (FY)
  2006 – 2007
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Musashino University
薬物代謝酵素の遺伝子変異多型と抗がん剤の薬理反応強度との相関解析Principal Investigator
- Principal Investigator
  
  谷川原祐介
- Project Period (FY)
  2004
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas
- Review Section
  
  Biological Sciences
- Research Institution
  Keio University
New biomarkers for acute rejection and therapeutic effect of immunosuppressive drugs in organ transplantation
- Principal Investigator
  
  MIHARA Kiyoshi
- Project Period (FY)
  2004 – 2005
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Keio University
薬物代謝酵素の遺伝子変異多型と抗がん剤の薬理反応強度との相関解析Principal Investigator
- Principal Investigator
  
  谷川原祐介
- Project Period (FY)
  2003
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas
- Review Section
  
  Biological Sciences
- Research Institution
  Keio University
Serum cystatin C as a new marker for determining the optimal dosage of renally excreted drugs.
- Principal Investigator
  
  MORITA Kunihiko
- Project Period (FY)
  2003 – 2004
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Keio University
薬物代謝酵素の遺伝子変異多型と抗がん剤の薬理反応強度との相関解析Principal Investigator
- Principal Investigator
  
  谷川原祐介
- Project Period (FY)
  2002
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas
- Review Section
  
  Biological Sciences
- Research Institution
  Keio University
Development of rational immunosuppressive therapy in organ transplantation based on pharmacogenomic and proteomic researchPrincipal Investigator
- Principal Investigator
  
  TANIGAWARA Yusuke
- Project Period (FY)
  2002 – 2004
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  応用薬理学・医療系薬学
- Research Institution
  Keio University
The prediction of adverse effect and determination of the maximum tolerated dose in chemotherapy of lung cancer based on clinical and molecular pharmacology
- Principal Investigator
  
  KONDO Keiichi
- Project Period (FY)
  2002 – 2003
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  HIROSHIMA UNIVERSITY
CYP2C9とVII因子の遺伝子診断に基づく抗凝固薬物療法の個別化Principal Investigator
- Principal Investigator
  
  谷川原祐介
- Project Period (FY)
  2001
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas (C)
- Review Section
  
  Biological Sciences
- Research Institution
  Keio University
薬物代謝酵素の遺伝子変異多型と抗がん剤の薬理反応強度との相関解析Principal Investigator
- Principal Investigator
  
  谷川原祐介
- Project Period (FY)
  2001
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas (C)
- Review Section
  
  Biological Sciences
- Research Institution
  Keio University
Optimization of Antibiotic Chemotherapy Based on Pharmacokinetics and Phannacodynamics of Antibiotics in Patients with Severe Infections
- Principal Investigator
  
  MORITA Kunihiko
- Project Period (FY)
  2001 – 2002
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  応用薬理学・医療系薬学
- Research Institution
  Keio University
CYP2C9の遺伝子診断に基づく抗凝固薬物療法の個別化Principal Investigator
- Principal Investigator
  
  谷川原祐介
- Project Period (FY)
  2000
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas (C)
- Review Section
  
  Biological Sciences
- Research Institution
  Keio University
薬物代謝酵素の遺伝子変異多型と抗がん剤の薬理反応強度との相関解析Principal Investigator
- Principal Investigator
  
  谷川原祐介
- Project Period (FY)
  2000
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas (C)
- Review Section
  
  Biological Sciences
- Research Institution
  Keio University
Development of Drug Monitoring System in Determining Optimal Dosage of Anticancer DrugsPrincipal Investigator
- Principal Investigator
  
  TANIGAWARA Yusuke
- Project Period (FY)
  2000 – 2002
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  応用薬理学・医療系薬学
- Research Institution
  Keio University
Multiple analysis concerning therapeutic significance of drug-metabolizing enzyme CYP2C9 polymorphismPrincipal Investigator
- Principal Investigator
  
  TANIGAWARA Yusuke
- Project Period (FY)
  2000 – 2001
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  応用薬理学・医療系薬学
- Research Institution
  Keio University
P-Glycoproten as a Molecular Target of Pharmacokinetic Studies for the Reversal of Multidrug ResistancePrincipal Investigator
- Principal Investigator
  
  TANIGAWARA Yusuke
- Project Period (FY)
  1996 – 1997
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  応用薬理学・医療系薬学
- Research Institution
  KOBE UNIVERSITY
臨床応用可能な抗がん剤耐性マーカーの探索とその克服
- Principal Investigator
  
  桑野信彦
- Project Period (FY)
  1995
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas
- Research Institution
  Kyushu University
Prediction of Pharmacokinetics and Efficacy/Toxicity by Genotypes of Metabolic Enzymes
- Principal Investigator
  
  OKUMURA Katsuhiko
- Project Period (FY)
  1995 – 1997
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  応用薬理学・医療系薬学
- Research Institution
  KOBE UNIVERSITY
Biostatistical Modeling for Pharmacokinetics and Pharmacodynamics of Anticancer Agents and Application to Individualized Dosage RegimenPrincipal Investigator
- Principal Investigator
  
  TANIGAWARA Yusuke
- Project Period (FY)
  1995 – 1996
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Physical pharmacy
- Research Institution
  KOBE UNIVERSITY
PHARMACEUTICAL STUDY FOR THERAPY OF LUNG DISEASES USING HUMAN SOD GENE TRANSFORMED CELLS
- Principal Investigator
  
  OKUMURA Katsuhiko
- Project Period (FY)
  1995 – 1996
- Research Category
  
  Grant-in-Aid for Scientific Research (A)
- Research Field
  
  応用薬理学・医療系薬学
- Research Institution
  DEPARTMENT OF HOSPITAL PHARMACY,SCHOOL OF MEDICINE,KOBE UNIVERSITY
P糖蛋白質を分子標的とする耐性克服治療システムの開発とその臨床応用
- Principal Investigator
  
  植田和光
- Project Period (FY)
  1994
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas
- Research Institution
  Kyoto University
Pharmacokinetic Studies on Drug Excretion Mechanism Mediated by P-GlycoproteinPrincipal Investigator
- Principal Investigator
  
  TANIGAWARA Yusuke
- Project Period (FY)
  1994 – 1995
- Research Category
  
  Grant-in-Aid for General Scientific Research (C)
- Research Field
  
  医薬分子機能学
- Research Institution
  KOBE UNIVERSITY
P-糖蛋白質の正常機能解析と誘導発現機構解析に基づいた多剤耐性克服法の開発
- Principal Investigator
  
  植田和光
- Project Period (FY)
  1993
- Research Category
  
  Grant-in-Aid for Cancer Research
- Research Institution
  Kyoto University
P-糖蛋白質の正常機能解析と誘導発現機構解析に基づいた多剤耐性克服法の開発
- Principal Investigator
  
  UEDA Kazumitsu
- Project Period (FY)
  1992
- Research Category
  
  Grant-in-Aid for Cancer Research
- Research Institution
  Kyoto University
Molecular mechanism of steroid transporter P-glycoprotein
- Principal Investigator
  
  UEDA Kazumitsu
- Project Period (FY)
  1992 – 1993
- Research Category
  
  Grant-in-Aid for General Scientific Research (C)
- Research Field
  
  応用生物化学・栄養化学
- Research Institution
  KYOTO UNIVERSITY
Scientific Basis of Drug Disposition in the Kidney and its Application to Clinical Dosage Regimens.
- Principal Investigator
  
  HORI Ryohei
- Project Period (FY)
  1991 – 1992
- Research Category
  
  Grant-in-Aid for General Scientific Research (B)
- Research Field
  
  Physical pharmacy
- Research Institution
  KYOTO UNIVERSITY
Development of new methods for the evaluation and protection of drug induced nephrotoxicity using kidney epithelial cell line (LLC-PK_1)
- Principal Investigator
  
  HORI Ryohei
- Project Period (FY)
  1988 – 1989
- Research Category
  
  Grant-in-Aid for Developmental Scientific Research
- Research Field
  
  応用薬理学・医療系薬学
- Research Institution
  KYOTO UNIVERSITY
Pharmacokinetics and Pharmacodynamics of Antiarrhythmic Drugs in Disease State
- Principal Investigator
  
  HORI Ryohei
- Project Period (FY)
  1987 – 1989
- Research Category
  
  Grant-in-Aid for General Scientific Research (B)
- Research Field
  
  応用薬理学・医療系薬学
- Research Institution
  KYOTO UNIVERSITY
Application of population pharmacokinetics to the individualization of drug dosage regimen.
- Principal Investigator
  
  HORI Ryohei
- Project Period (FY)
  1985 – 1986
- Research Category
  
  Grant-in-Aid for Developmental Scientific Research
- Research Field
  
  応用薬理学・医療系薬学
- Research Institution
  Kyoto University

[Book] 薬物動態・薬力学から見たがん個別化治療の現状と展望2014
- Author(s)
  谷川原祐介
- Publisher
  日本臨床社
- Data Source
  KAKENHI-PROJECT-23390037
[Book] 薬物動態・薬力学から見たがん個別化治療の現状と展望，日本臨牀 72巻　増刊号22014
- Author(s)
  谷川原祐介
- Total Pages
  7
- Publisher
  日本臨牀社
- Data Source
  KAKENHI-PROJECT-23390037
[Book] Population Pharmacokinetics解析法，薬剤学実験法必携マニュアルII2014
- Author(s)
  谷川原祐介、笠井英史
- Total Pages
  17
- Publisher
  南江堂
- Data Source
  KAKENHI-PROJECT-23390037
[Book] ポピュレーション・ファーマコキネティクス，医療薬学　第６版2014
- Author(s)
  谷川原祐介
- Total Pages
  5
- Publisher
  廣川書店
- Data Source
  KAKENHI-PROJECT-23390037
[Book] 薬物治療モニタリング（TDM），今日の治療指針2013年版2013
- Author(s)
  谷川原祐介
- Total Pages
  13
- Publisher
  医学書院
- Data Source
  KAKENHI-PROJECT-23390037
[Book] 化学療法の領域27(1)(巻頭言:個別化投薬-過去,現在,未来-)2011
- Author(s)
  谷川原祐介
- Total Pages
  15
- Publisher
  医療ジャーナル社
- Data Source
  KAKENHI-PROJECT-23390037
[Book] 薬物治療モニタリング(TDM)2011
- Author(s)
  谷川原祐介
- Total Pages
  1575
- Publisher
  医学書院
- Data Source
  KAKENHI-PROJECT-23390037
[Book] 安全医学7(1)2011
- Author(s)
  谷川原祐介
- Total Pages
  47
- Publisher
  日本予防医学リスクマネージメント学会
- Data Source
  KAKENHI-PROJECT-23390037
[Book] 薬事日報,第10927号(がん専門薬剤師認定制度の現状)2011
- Author(s)
  谷川原祐介
- Total Pages
  12
- Publisher
  薬事日報社
- Data Source
  KAKENHI-PROJECT-23390037
[Book] Mebio Oncology6(PK/PDバイオマーカーに基づく抗がん剤治療の個別化)2009
- Author(s)
  谷川原祐介
- Publisher
  メディカルビュー社,
- Data Source
  KAKENHI-PROJECT-20390049
[Book] Mebio Oncology非選択的治療から選択的治療へのパラダイムシフト2009
- Author(s)
  谷川原祐介
- Publisher
  メディカルビュー社
- Data Source
  KAKENHI-PROJECT-20014025
[Book] 医学のあゆみ231(抗癌剤反応性のメタボローム解析-癌細胞の薬剤応答解明と個別化医療実現に向けた新戦略)2009
- Author(s)
  西牟田章戸,谷川原祐介
- Publisher
  医歯薬出版
- Data Source
  KAKENHI-PROJECT-20390049
[Book] がん薬物療法学-基礎・臨床研究のアップデートー2009
- Author(s)
  谷川原祐介
- Publisher
  日本臨床社
- Data Source
  KAKENHI-PROJECT-20014025
[Book] がん薬物療法学-基礎・臨床研究のアップデート-2009
- Author(s)
  谷川原祐介
- Publisher
  日本臨床社
- Data Source
  KAKENHI-PROJECT-20390049
[Book] Mebio Oncology 非選択的治療から選択的治療へのパラダイムシフト2009
- Author(s)
  谷川原祐介
- Publisher
  メディカルビュー社
- Data Source
  KAKENHI-PROJECT-20390049
[Book] 今日の治療指針20082008
- Author(s)
  谷川原祐介
- Publisher
  医学書院
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-18390053
[Book] 今日の治療指針 20082008
- Author(s)
  谷川原祐介
- Publisher
  医学書院
- Data Source
  KAKENHI-PROJECT-18390053
[Book] がん化学療法副作用グレード評価シート2008
- Author(s)
  谷川原祐介
- Total Pages
  128
- Publisher
  南山堂
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-18390053
[Book] 生物薬剤学改訂第2版2007
- Author(s)
  谷川原祐介(編)
- Total Pages
  261
- Publisher
  南江堂
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-18390053
[Book] 安全で有効な外来がん化学療法の実践2007
- Author(s)
  谷川原祐介
- Publisher
  先端医学社
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-18390053
[Book] スタンダード薬学シリーズ10実務事前実習病院、薬局に行く前に2006
- Author(s)
  谷川原祐介
- Publisher
  東京化学同人
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-18390053
[Journal Article] Prospective evaluation and refinement of an S-1 dosage formula based on renal function for clinical application.2021
- Author(s)
  Takeuchi M, Imamura CK, Booka E, Takeuchi H, Mizukami T, Kawakami T, Funakoshi T, Wakuda K, Aoki Y, Hamamoto Y, Kitago M, Kawakubo H, Boku N, Tanigawara Y, Kitagawa Y.
- Journal Title
  
  Cancer Science
  
  Volume: 112 Issue: 2 Pages: 751-759
- DOI
  10.1111/cas.14758
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K08961
[Journal Article] Clinical practice guidelines for therapeutic drug monitoring of arbekacin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring2014
- Author(s)
  Okada K, Kimura T, Mikamo H, Kasahara K, Seki M, Takakura S, Tokimatsu I, Ohmagari N, Takahashi Y, Matsumoto K, Igarashi M, Kobayashi M, Hamada Y, Mochizuki T, Kimura M, Nishi Y, Tanigawara Y, Takesue Y
- Journal Title
  
  J Infect Chemother
  
  Volume: 20(1) Issue: 1 Pages: 1-5
- DOI
  10.1016/j.jiac.2013.08.008
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23390037
[Journal Article] Forced expression of S100A10 reduces sensitivity to oxaliplatin in colorectal cancer cells2014
- Author(s)
  Suzuki S, Tanigawara Y
- Journal Title
  
  Proteome Science
  
  Volume: 12 Issue: 1 Pages: 26-26
- DOI
  10.1186/1477-5956-12-26
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23390037, KAKENHI-PROJECT-24590208
[Journal Article] Practice guidelines for therapeutic drug monitoring of voriconazole: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring2013
- Author(s)
  Hamada Y, Tokimatsu I, Mikamo H, Kimura M, Seki M, Takakura S, Ohmagari N, Takahashi Y, Kasahara K, Matsumoto K, Okada K, Igarashi M, Kobayashi M, Mochizuki T, Nishi Y, Tanigawara Y, Kimura T, Takesue Y
- Journal Title
  
  J Infect Chemother
  
  Volume: 19(3) Issue: 3 Pages: 381-392
- DOI
  10.1007/s10156-013-0607-8
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23390037
[Journal Article] Practice guidelines for therapeutic drug monitoring of vancomycin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring2013
- Author(s)
  Matsumoto K, Takesue Y, Ohmagari N, Mochizuki T, Mikamo H, Seki M, Takakura S, Tokimatsu I, Takahashi Y, Kasahara K, Okada K, Igarashi M, Kobayashi M, Hamada Y, Kimura M, Nishi Y, Tanigawara Y, Kimura T
- Journal Title
  
  J Infect Chemother
  
  Volume: 19(3) Issue: 3 Pages: 365-380
- DOI
  10.1007/s10156-013-0599-4
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23390037, KAKENHI-PROJECT-23591485
[Journal Article] Polymorphisms in the UGT1A1 gene predict adverse effects of irinotecan in the treatment of gynecologic cancer in Japanese patients2013
- Author(s)
  Hirasawa A, Zama T, Akahane T, Nomura H, Kataoka F, Saito K, Okubo K, Tominaga E, Makita K, Susumu N, Kosaki K, Tanigawara Y, Aoki D
- Journal Title
  
  J Hum Genet
  
  Volume: 58(12) Issue: 12 Pages: 794-8
- DOI
  10.1038/jhg.2013.105
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23390037, KAKENHI-PROJECT-25462609
[Journal Article] Clinical dose findings of sitafloxacin treatment: pharmacokinetic-pharmacodynamic analysis of two clinical trial results for community-acquired respiratory tract infections2013
- Author(s)
  Kohno S, Niki Y, Kadota J, Yanagihara K, Kaku M, Watanabe A, Aoki N, Hori S, Fujita J, Tanigawara Y
- Journal Title
  
  J Infect Chemother
  
  Volume: 19(3) Issue: 3 Pages: 486-494
- DOI
  10.1007/s10156-012-0543-z
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23390037
[Journal Article] Clinical and bacteriological efficacies of sitafloxacin against community-acquired pneumonia caused by Streptococcus pneumoniae: nested cohort within a multicenter clinical trial2013
- Author(s)
  Fujita J, Niki Y, Kadota J, Yanagihara K, Kaku M, Watanabe A, Aoki N, Hori S, Tanigawara Y, Cash HL, Kohno S
- Journal Title
  
  J Infect Chemother
  
  Volume: 19(3) Issue: 3 Pages: 472-479
- DOI
  10.1007/s10156-012-0514-4
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23390037
[Journal Article] Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patients2013
- Author(s)
  Kim HR, Park HS, Kwon WS, Lee JH, Tanigawara Y, Lim SM, Kim HS, Shin SJ, Ahn JB, Rha SY
- Journal Title
  
  Cancer Chemother Pharmacol
  
  Volume: 72(4) Issue: 4 Pages: 825-35
- DOI
  10.1007/s00280-013-2258-y
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23390037
[Journal Article] Population pharmacokinetics and pharmacodynamics of sitafloxacin in patients with community-acquired respiratory tract infections2013
- Author(s)
  Tanigawara Y, Kaku M, Totsuka K, Tsuge H, Saito A
- Journal Title
  
  J Infect Chemother
  
  Volume: 19(5) Issue: 5 Pages: 858-866
- DOI
  10.1007/s10156-013-0580-2
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23390037
[Journal Article] Dose-adjustment study of tamoxifen based on CYP2D6 genotypes in Japanese breast cancer patients2012
- Author(s)
  Kiyotani, K., et.al.
- Journal Title
  
  Breast Cancer Res Treat
  
  Volume: 131(1) Issue: 1 Pages: 137-45
- DOI
  10.1007/s10549-011-1777-7
- Peer Reviewed
- Data Source
  KAKENHI-PLANNED-22116010, KAKENHI-PROJECT-22790179, KAKENHI-PROJECT-23390037, KAKENHI-PROJECT-221S0001
[Journal Article] Blood-direct InvaderPlus as a new method for genetic testing2012
- Author(s)
  Hirasawa A, Akahane T, Tanigawara Y, Aoki D
- Journal Title
  
  Personalized Medicine
  
  Volume: 9 Issue: 6 Pages: 657-663
- DOI
  10.2217/pme.12.71
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23390037
[Journal Article] Expression changes in arrestin β1 and genetic variation in catechol-O-methyltransferase are biomarkers for the response to morphine treatment in cancer patients2011
- Author(s)
  H.Matsuoka, T.Arao, C.Makimura, M.Takeda, H.Kiyota, J.Tsurutani, Y.Fujita, K.Matsumoto, H.Kimura, M.Otsuka, A.Koyama, CK.Imamura, Y.Tanigawara, T.Yamanaka, K.Tanaka, K.Nishio, K.Nakagawa
- Journal Title
  
  Oncology Reports
  
  Volume: 27(5) Pages: 1393-9
- DOI
  10.3892/or.2012.1660
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23390037, KAKENHI-PROJECT-23650627, KAKENHI-PROJECT-23701106, KAKENHI-PROJECT-23790820
[Journal Article] A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in Japanese2011
- Author(s)
  K.Kiyotani, T.Mushiroda, T.Tsunoda, T Morizono, N Hosono, M.Kubo, Y.Tanigawara, CK.Imamura, DA Flockhart, F.Aki, K.Hirata, Y.Takatsuka, M.Okazaki, S.Ohsumi, T.Yamakawa, M.Sasa, Y.Nakamura, H.Zembutsu
- Journal Title
  
  Hum Mol Genet
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23390037
[Journal Article] Optimal treatment schedule of meropenem for adult patients with febrile neutropenia based on pharmacokinetic-pharmacodynamic analysis2011
- Author(s)
  Y.Ohata, Y.Tomita, M.Nakayama, K.Tamura, Y.Tanigawara
- Journal Title
  
  J.Infect.Chemother.
  
  Volume: 17 Issue: 6 Pages: 831-841
- DOI
  10.1007/s10156-011-0271-9
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23390037
[Journal Article] Levofloxacin注射剤の母集団薬物動態/薬力学解析2011
- Author(s)
  谷川原祐介, 清水貴子, 戸塚恭一
- Journal Title
  
  日本化学療法学会雑誌
  
  Volume: 59(S-1) Pages: 55-63
- NAID
  10028244755
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23390037
[Journal Article] A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures-a randomized active comparator, double-blind study2011
- Author(s)
  T.Matsumoto, M.Ito, Y.Hayashi, T.Hirota, Y.Tanigawara
- Journal Title
  
  Bone
  
  Volume: 49(4) Pages: 605-612
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23390037
[Journal Article] Pharmacokinetics of eldecalcitol, a new active D3 derivative2011
- Author(s)
  M.Abe, N.Tsuji, F.Takahashi, Y.Tanigawara
- Journal Title
  
  Jpn.Pharmacol.Ther.
  
  Volume: 39 Pages: 261-274
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23390037
[Journal Article] A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in Japanese2011
- Author(s)
  K.Kiyotani, T.Mushiroda, T.Tsunoda, T.Morizono, N.Hosono, M.Kubo, Y.Tanigawara, CK.Imamura, DA.Flockhart, F.Aki, K.Hirata, Y.Takatsuka, M.Okazaki, S.Ohsumi, T.Yamakawa, M.Sasa, Y.Nakamura, H.Zembutsu
- Journal Title
  
  Human Molecular Genetics
  
  Volume: (オンライン出版済) Issue: 7 Pages: 1665-1672
- DOI
  10.1093/hmg/ddr597
- Peer Reviewed
- Data Source
  KAKENHI-PLANNED-22134008, KAKENHI-PROJECT-22790179, KAKENHI-PROJECT-23390037, KAKENHI-PROJECT-24300338
[Journal Article] Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure2011
- Author(s)
  M.Watanabe, Y.Horai, S.M.Houten, K.Morimoto, T.Sugizaki, E.Arita, C.Mataki, H.Sato, Y.Tanigawara
- Journal Title
  
  J.Biol.Chem.
  
  Volume: 286(30) Pages: 26913-20
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23390037
[Journal Article] Pharmacokinetics of eldecalcitol in primary osteoporosis patients-Randomaized, double-blind, multicentre, long-term phase III clinical Study2011
- Author(s)
  K.Miyata, M.Abe, K.Terao, T.Kawanishi, N.Tsuji, M.Shiraki, T.Nakamura, T.Matsumoto, Y.Tanigawara
- Journal Title
  
  Jpn.Pharmacol.Ther.
  
  Volume: 39 Pages: 299-307
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23390037
[Journal Article] Optimal dose finding of garenoxacin based on population pharmacokinetics/pharmacodynamics and Monte Carlo simulation2011
- Author(s)
  Y.Tanigawara, K.Nozawa, H Tsuda
- Journal Title
  
  Eur.J.Clin.Pharmacol.
  
  Volume: 51 Issue: 1 Pages: 1276-1285
- DOI
  10.1007/s00228-011-1095-3
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23390037
[Journal Article] S100A10 protein expression is associated with oxaliplatin sensitivity in human colorectal cancer cells2011
- Author(s)
  Suzuki S, Yamayoshi Y, Nishimuta A, Tanigawara Y.
- Journal Title
  
  Proteome Science
  
  Volume: 9 Issue: 1 Pages: 76-76
- DOI
  10.1186/1477-5956-9-76
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590176, KAKENHI-PROJECT-23390037
[Journal Article] Optimal dosage regimen of meropenem for pediatric patients based on pharmacokinetic/pharmacodynamic considerations2011
- Author(s)
  Y.Ohata, Y.Tomita, M.Nakayama, T.Kozuki, K.Sunakawa, Y.Tanigawara
- Journal Title
  
  Drug Metab.Pharmacokinet.
  
  Volume: 26(5) Pages: 523-531
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23390037
[Journal Article] Greater impact of oral fluconazole on drug interaction with intravenous calcineurin inhibitors as compared with intravenous fluconazole2008
- Author(s)
  Mihara A, Mori T, Aisa Y, Yamazaki R, Iketani O, Tanigawara Y, Ikeda Y, Okamoto S.
- Journal Title
  
  Eur J Clin Pharmacol 64
  
  Pages: 89-91
- Data Source
  KAKENHI-PROJECT-19390255
[Journal Article] Greater impact of oral fluconazole on drug interaction with intravenous calcineurin inhibitors as compared with intravenous fluconazole.2008
- Author(s)
  Mihara A, Mori T, Aisa Y, Yamazaki R, Iketani O, Tanigawara Y, Ikeda Y, Okamoto S
- Journal Title
  
  Eur J Clin Pharmacol. 64
  
  Pages: 89-91
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19390255
[Journal Article] Phase I/II study of oxaliplatin with oral S-1 as first-line therapy for patients with metastatic colorectal cancer.2008
- Author(s)
  Yamada Y, Tanigawara Y, et. al.
- Journal Title
  
  Br J Caneer. 25
  
  Pages: 1034-1038
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18590155
[Journal Article] Phase I/II study of oxaliplatin with oral S-1 as first-line therapy for patients with metastati colorectal cancer2008
- Author(s)
  Yamada Y, Tanigawara Y., et. al.
- Journal Title
  
  Br J Cancer. 25
  
  Pages: 1034-1038
- Description
  「研究成果報告書概要(和文)」より
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18590155
[Journal Article] Greater impact of oral fluconazole on drug interaction with intravenous calcineurin inhibitors as compared with intravenous fluconazole2008
- Author(s)
  Mihara A, Tanigawara Y, et. al.
- Journal Title
  
  Eur J Clin Pharlnacol 64
  
  Pages: 89-91
- Description
  「研究成果報告書概要(和文)」より
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18590155
[Journal Article] Phase I/II study of oxaliplatin with oral S-1 as first-line therapy for patients with metastatic colorectal cancer.2008
- Author(s)
  Yamada Y, Tanigawara Y, et. al.
- Journal Title
  
  Br J Cancer. 98(6)
  
  Pages: 1034-1038
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18590155
[Journal Article] Greater impact of oral fluconazole on drug interaction with intravenous calcineurin inhibitors as compared with intravenous fluconazole.2008
- Author(s)
  Mihara A, Tanigawara Y, et. al.
- Journal Title
  
  Eur J Chin Pharmacol. 64
  
  Pages: 89-91
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18590155
[Journal Article] Greater impact of oral fluconazole on drug interaction with intravenous calcineurin inhibitors as compared with intravenous fluconazole.2008
- Author(s)
  Mihara A, Tanigawara Y, et. al.
- Journal Title
  
  Eur J Clin Pharmacol. 64(1)
  
  Pages: 89-91
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18590155
[Journal Article] Phase II study of oxaliplatin in japanese patients with metastatic colorectal cancer refractory to fluoropyrimidines.2007
- Author(s)
  Boku N, Tanigawara Y, et. al.
- Journal Title
  
  Jpn J Clin Oncol. 37(6)
  
  Pages: 440-445
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18590155
[Journal Article] Phase II Study of Oxaliplatin in Japanese Patients with Metastatic Colorectal Cancer Refractory to Fluoropyrimidines2007
- Author(s)
  Boku N, Ohtsu A, Hyodo I, Shirao K, Miyata Y, Nakagawa K, Tamura T, Hatake K, Tanigawara Y.
- Journal Title
  
  Jpn J Clin Oncol 37
  
  Pages: 440-445
- Data Source
  KAKENHI-PROJECT-19390255
[Journal Article] Pharmacokinetic-pharmacodynamic relationship of arbekacin for treatment of patients infected with methicillin-resistant Staphylococcus aureus.2006
- Author(s)
  Sato R, Tanigawara Y, et. al.
- Journal Title
  
  Antimicrob Agents Chemother. 50(11)
  
  Pages: 3763-5769
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18590155
[Journal Article] Effects of methylenetetrahydrofolate reductase and reduced folate carrier 1 polymorphisms on high-dose methotrexate-induced toxicities in children with acute lymphoblastic leukemia or lymphoma2006
- Author(s)
  Shimasaki N, Tanigawara Y, et al.
- Journal Title
  
  J.Pediatr.Hematol.Oncol. 28・2
  
  Pages: 64-68
- Data Source
  KAKENHI-PROJECT-16590121
[Journal Article] Population Pharmacokinetics of Arbekacin in Patients Infected with Methicillin-Resistant Stapylococcus Aureus.2006
- Author(s)
  Y.Tanigawara
- Journal Title
  
  Antimicrobial Agents Chemother. 50(11)
  
  Pages: 3754-3762
- Data Source
  KAKENHI-PROJECT-18390053
[Journal Article] Novel application of ProteinChip technology exploring acute rejection markers of rat small bowel transplantation.2006
- Author(s)
  Yamayoshi Y, Tanigawara Y, et al.
- Journal Title
  
  Transplantation 82・3
  
  Pages: 320-326
- Data Source
  KAKENHI-PROJECT-18590155
[Journal Article] Population pharmacokinetics of Arbekacin in patients infected with methicillin-resistant Staphylococcus aureus.2006
- Author(s)
  Tanigawara Y., Sato R, et al.
- Journal Title
  
  Antimicrob. Agents Chemother. 50・11
  
  Pages: 3754-3762
- Data Source
  KAKENHI-PROJECT-18590155
[Journal Article] Effects of methylenetetrahydrofolate reductase and reduced folate carrier 1 polymorphisms on high-dose methotrexate-induced toxicities in children with acute lymphoblastic leukemia or lymphoma2006
- Author(s)
  Shimasaki N, Tanigawara Y, et al.
- Journal Title
  
  J.Pediatr.Hematol.Oncol. 28(2)
  
  Pages: 64-68
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-16590121
[Journal Article] Population pharmacokinetic analysis of micafungin in Japanese patients with fungal infections.2006
- Author(s)
  Tabata K, Tanigawara Y, et al.
- Journal Title
  
  Drug Metab. Pharmacokinet. 21・4
  
  Pages: 324-331
- Data Source
  KAKENHI-PROJECT-18590155
[Journal Article] Pharmacokingetic-pharmacodynamic relationship of arbekacin for treatment of patients infected with methicillin-resistant Staphylococcus aureus.2006
- Author(s)
  Sato R, Tanigawara Y, et al.
- Journal Title
  
  Antimicrob. Agents Chemother. 50・11
  
  Pages: 3763-3769
- Data Source
  KAKENHI-PROJECT-18590155
[Journal Article] Population pharmacokinetics of arbekacin in patients infected with Methicillin-resistant Staphylococcus aureus2006
- Author(s)
  Y.Tanigawara
- Journal Title
  
  Antimicrobial Agents Chemother 50
  
  Pages: 3754-3765
- Description
  「研究成果報告書概要(和文)」より
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18390053
[Journal Article] Pharmacokinetic-pharmacodynamic relationship of arbekacin for treatment of patients infected with methicillin-resistant Staphylococcus aureus.2006
- Author(s)
  Tanigawara Y. Sato R, et. al.
- Journal Title
  
  Antimicrob Agents Chemother. 50(11)
  
  Pages: 3754-3762
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18590155
[Journal Article] Effects of methylenetetrahydrofolate reductase and reduced folate carrier 1 polymorphisms on high-dose methotrexate-induced toxicities in children with acute lymphoblastic leukemia or lymphoma2006
- Author(s)
  Shimasaki N, Tanigawara Y, et al.
- Journal Title
  
  J. Pediatr. Hematol. Oncol. 28・2
  
  Pages: 64-68
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-16590121
[Journal Article] Population pharmacokinetics of arbekacin in patients infected with Methicillin-resistant Staphylococcus aureus2006
- Author(s)
  Y., Tanigawara
- Journal Title
  
  Antimicrobial Agents Chemother 50
  
  Pages: 3754-3762
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18390053
[Journal Article] Comprehensive screening of the thiopurine methyltransferase polymorphisms by denaturing high-performance liquid chromatography2005
- Author(s)
  Udaka T, Tanigawara Y, et al.
- Journal Title
  
  Genet.Test 9・2
  
  Pages: 85-92
- Data Source
  KAKENHI-PROJECT-16590121
[Journal Article] Anew active vitamin D, ED-71, increases bone mass in osteoporotic patients under vitamin D supplementation : a randomized, double-blind, placebo-controlled clinical trial2005
- Author(s)
  Matsumoto T, Tanigawara Y, et al.
- Journal Title
  
  J. Clin. Endocrinol. Metab. 90・9
  
  Pages: 5031-5036
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-16590121
[Journal Article] Cancer Pharmacogenomics : International Trends2005
- Author(s)
  Yamayoshi Y, Iida E, Tanigawara Y
- Journal Title
  
  Int.J.Clin.Oncol. 10
  
  Pages: 5-13
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-14370787
[Journal Article] Comprehensive screening of the thiopurine methyltransferase polymorphisms by denaturing high-performance liquid chromatography2005
- Author(s)
  Udaka T, Tanigawara Y, et al.
- Journal Title
  
  Genet. Test 9・2
  
  Pages: 85-92
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-16590121
[Journal Article] Cancer Pharmacogenomics : International Trends2005
- Author(s)
  Yamayoshi Y, Tanigawara Y, et al.
- Journal Title
  
  Int. J. Clin. Oncol. 10・1
  
  Pages: 5-13
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-16590121
[Journal Article] Phase I and pharmacokinetic study of edotecarin, a novel topoisomerase I inhibitor, administered once every 3 weeks in patients with solid tumors2005
- Author(s)
  Yamada Y, Tanigawara Y, et al.
- Journal Title
  
  Cancer Chemother.Pharmacol. 25
  
  Pages: 1-10
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-16590121
[Journal Article] Cancer Pharmacogenomics : International Trends2005
- Author(s)
  Yamayoshi Y, Tanigawara Y, et al.
- Journal Title
  
  Int.J.Clin.Oncol. 10(1)
  
  Pages: 5-13
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-16590121
[Journal Article] Cancer Pharmacogenomics : International Trends2005
- Author(s)
  Yamayoshi Y, Tanigawara Y, et al.
- Journal Title
  
  Int.J.Clin.Oncol. 10・1
  
  Pages: 5-13
- Data Source
  KAKENHI-PROJECT-16590121
[Journal Article] Comprehensive screening of the thiopurine methyltransferase polymorphisms by denaturing high-performance liquid chromatography2005
- Author(s)
  Udaka T, Tanigawara Y, et al.
- Journal Title
  
  Genet.Test 9(2)
  
  Pages: 85-92
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-16590121
[Journal Article] A new active vitamin D, ED-71, increases bone mass in osteoporotic patients under vitamin D supplementation : a randomized, double-blind, placebo-controlled clinical trial2005
- Author(s)
  Matsumoto T, Tanigawara Y, et al.
- Journal Title
  
  J.Clin.Endocrinol.Metab. 90(9)
  
  Pages: 5031-5036
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-16590121
[Journal Article] Cancer Pharmacogenomics : International Trends2005
- Author(s)
  Yamayoshi Y, Iida E, Tanigawara Y
- Journal Title
  
  Int.J.Clin.Oncol. 10・1
  
  Pages: 5-13
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-14370787
[Journal Article] Phase I and pharmacokinetic study of edotecarin, a novel topoisomerase I inhibitor, administered once every 3 weeks in patients with solid tumors2005
- Author(s)
  Yamada Y, Tanigawara Y, et al.
- Journal Title
  
  Cancer Chemother. Pharmacol. 25
  
  Pages: 1-10
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-16590121
[Journal Article] Cancer Pharmacogenomics : International Trends2005
- Author(s)
  Yamayoshi Y, Iida E, Tanigawara Y
- Journal Title
  
  Int.J.Clin.Oncol. 10・1
  
  Pages: 5-13
- Data Source
  KAKENHI-PROJECT-16023265
[Journal Article] A new active vitamin D, ED-71, increases bone mass in osteoporotic patients under vitamin D supplementation : a randomized, double-blind, placebo-controlled clinical trial2005
- Author(s)
  Matsumoto T, Tanigawara Y, et al.
- Journal Title
  
  J.Clin.Endocrinol.Metab. 90・9
  
  Pages: 5031-5036
- Data Source
  KAKENHI-PROJECT-16590121
[Journal Article] Phorbol myristate acetate stimulates degradation of a structural analogue of platelet-activating factor to a neutral lipid in human leukemic K562 cells : relevance to the release of lipids2004
- Author(s)
  Tsutsumi T, Tanigawara Y, et al.
- Journal Title
  
  Biol.Pharm.Bull. 27・1
  
  Pages: 24-28
- Data Source
  KAKENHI-PROJECT-16023265
[Journal Article] A randomized phase II clinical trial of tailored CPT-11 + S-1 vs S-1 in patients with advanced or recurrent gastric carcinoma as the first line chemotherapy2004
- Author(s)
  Takahashi Y, Tanigawara Y, et al.
- Journal Title
  
  Jpn.J.Clin.Oncol. 34
  
  Pages: 342-345
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-14370787
[Journal Article] A major influence of CYP2C19 genotype on the steady-state concentration of N-desmethylclobazam2004
- Author(s)
  Kosaki K, Tanigawara Y, et al.
- Journal Title
  
  Brain Dev. 26・8
  
  Pages: 530-534
- Data Source
  KAKENHI-PROJECT-16023265
[Journal Article] A major influence of CYP2C19 genotype on the steady-state concentration of N-desmethylclobazam2004
- Author(s)
  Kosaki K, Tanigawara Y, et al.
- Journal Title
  
  Brain Dev. 26・8
  
  Pages: 530-534
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-14370787
[Journal Article] Phorbol myristate acetate stimulates degradation of a structural analogue of platelet-activating factor to a neutral lipid in human leukemic K562 cells : relevance to the release of lipids2004
- Author(s)
  Tsutsumi T, Tanigawara Y, et al.
- Journal Title
  
  Biol.Pharm.Bull. 27・1
  
  Pages: 24-28
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-14370787
[Journal Article] Relationship between pharmacokinetic parameters and occurrence of adverse events in clinical trials performed in Europe and United States for an angiotensin II receptor antagonist. telmisartan2004
- Author(s)
  Tatami S, Tanigawara Y, et al.
- Journal Title
  
  Drug Metab.Pharmacokinet. 19・1
  
  Pages: 24-32
- Data Source
  KAKENHI-PROJECT-16023265
[Journal Article] A major influence of CYP2C19 genotype on the steady-state concentration of N-desmethylclobazam2004
- Author(s)
  Kosaki K, Tanigawara Y, et al.
- Journal Title
  
  Brain Dev. 26
  
  Pages: 530-534
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-14370787
[Journal Article] A randomized phase II clinical trial of tailored CPT-11+S-1 vs S-1 in patients with advanced or recurrent gastric carcinoma as the first line chemotherapy2004
- Author(s)
  Takahashi Y, Tanigawara Y, et al.
- Journal Title
  
  Jpn.J.Clin.Oncol. 34・6
  
  Pages: 342-345
- Data Source
  KAKENHI-PROJECT-16023265
[Journal Article] Phorbol myristate acetate stimulates degradation of a structural analogue of platelet-activating factor to a neutral lipid in human leukemic K562 cells : relevance to the release of lipids2004
- Author(s)
  Tsutsumi T, Tanigawara Y, et al.
- Journal Title
  
  Biol.Pharm.Bull. 27
  
  Pages: 24-28
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-14370787
[Journal Article] A randomized phase II clinical trial of tailored CPT-11 + S-1 vs S-1 in patients with advanced or recurrent gastric carcinoma as the first line chemotherapy2004
- Author(s)
  Takahashi Y, Tanigawara Y, et al.
- Journal Title
  
  Jpn.J.Clin.Oncol. 34・6
  
  Pages: 342-345
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-14370787
[Journal Article] Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injection2004
- Author(s)
  Inoue M, Tanigawara, et al.
- Journal Title
  
  Am.J.Ophthalmol. 138・6
  
  Pages: 1046-1048
- Data Source
  KAKENHI-PROJECT-16023265
[Patent] 抗がん剤感受性判定マーカー2014
- Inventor(s)
  谷川原祐介, 渡辺光博, 有田恵理, 西牟田章戸, 山吉康子, 松崎健, 杉本伸二
- Industrial Property Rights Holder
  学校法人慶應義塾, 株式会社ヤクルト本社
- Industrial Property Rights Type
  特許
- Acquisition Date
  2014-03-12
- Overseas
- Data Source
  KAKENHI-PROJECT-23390037
[Patent] 抗がん剤感受性判定マーカー2014
- Inventor(s)
  谷川原祐介, 渡辺光博, 有田恵理, 西牟田章戸, 山吉康子, 松崎健, 杉本伸二
- Industrial Property Rights Holder
  学校法人慶應義塾, 株式会社ヤクルト本社
- Industrial Property Rights Type
  特許
- Acquisition Date
  2014-01-24
- Data Source
  KAKENHI-PROJECT-23390037
[Patent] 抗がん剤感受性の判定方法2014
- Inventor(s)
  谷川原祐介, 鈴木小夜, 杉本伸二
- Industrial Property Rights Holder
  学校法人慶應義塾, 株式会社ヤクルト本社
- Industrial Property Rights Type
  特許
- Acquisition Date
  2014-01-24
- Data Source
  KAKENHI-PROJECT-23390037
[Patent] 併用抗がん剤の感受性判定マーカー2012
- Inventor(s)
  谷川原祐介, 西牟田章戸, 津崎盾哉, 高橋寛行
- Industrial Property Rights Holder
  学校法人慶應義塾, 株式会社ヤクルト本社
- Industrial Property Rights Type
  特許
- Industrial Property Number
  2012-037448
- Filing Date
  2012-02-23
- Data Source
  KAKENHI-PROJECT-23390037
[Patent] 抗がん剤感受性の判定マーカー2012
- Inventor(s)
  谷川原祐介, 西牟田章戸, 大谷勇紀, 松尾光寿
- Industrial Property Rights Holder
  学校法人慶應義塾, 株式会社ヤクルト本社
- Industrial Property Rights Type
  特許
- Filing Date
  2012-03-24
- Overseas
- Data Source
  KAKENHI-PROJECT-23390037
[Patent] 抗がん剤感受性の判定マーカー2012
- Inventor(s)
  谷川原祐介, 西牟田章戸, 大谷勇紀, 松尾光寿
- Industrial Property Rights Holder
  学校法人慶應義塾株式会社ヤクルト本社
- Filing Date
  2012-03-24
- Overseas
- Data Source
  KAKENHI-PROJECT-23390037
[Patent] 抗がん剤の感受性の判定方法2012
- Inventor(s)
  谷川原祐介, 西牟田章戸, 鈴木小夜, 鈴木哲也, 生駒祐介, 杉本伸二
- Industrial Property Rights Holder
  学校法人慶應義塾, 株式会社ヤクルト本社
- Industrial Property Rights Type
  特許
- Acquisition Date
  2012-03-24
- Overseas
- Data Source
  KAKENHI-PROJECT-23390037
[Patent] 抗がん剤の感受性の判定方法2012
- Inventor(s)
  谷川原祐介、西牟田章戸、鈴木小夜、鈴木哲也、生駒祐介、杉本伸二
- Industrial Property Rights Holder
  谷川原祐介、西牟田章戸、鈴木小夜、鈴木哲也、生駒祐介、杉本伸二
- Industrial Property Rights Type
  特許
- Filing Date
  2012-04-30
- Acquisition Date
  2014-03-24
- Overseas
- Data Source
  KAKENHI-PROJECT-23390037
[Patent] 抗がん剤感受性の判定方法2011
- Inventor(s)
  谷川原祐介、鈴木小夜、杉本伸二
- Industrial Property Rights Holder
  学校法人慶應義塾、株式会社ヤクルト本社
- Acquisition Date
  2011-09-28
- Overseas
- Data Source
  KAKENHI-PROJECT-21590176
[Patent] 抗がん剤感受性の判定マーカー2011
- Inventor(s)
  谷川原祐介, 西牟田章戸, 大谷勇紀, 松尾光寿
- Industrial Property Rights Holder
  学校法人慶應義塾株式会社ヤクルト本社
- Industrial Property Number
  2011-065993
- Filing Date
  2011-03-24
- Data Source
  KAKENHI-PROJECT-23390037
[Patent] 抗がん剤の感受性判定方法2010
- Inventor(s)
  谷川原祐介, 鈴木小夜, 入江秀大, 西牟田章戸, 鈴木哲也, 杉本伸二
- Industrial Property Rights Holder
  学校法人慶應義塾株式会社ヤクルト本社
- Industrial Property Number
  2010-020456
- Filing Date
  2010
- Data Source
  KAKENHI-PROJECT-21590176
[Patent] 抗がん剤の感受性判定方法2010
- Inventor(s)
  谷川原祐介, 鈴木小夜, 入江秀大, 西牟田章戸, 鈴木哲也, 杉本伸二
- Industrial Property Rights Holder
  学校法人慶應義塾株式会社ヤクルト本社
- Filing Date
  2010-10-29
- Overseas
- Data Source
  KAKENHI-PROJECT-20390049
[Patent] 抗がん剤の感受性の判定方法2010
- Inventor(s)
  谷川原祐介, 鈴木小夜, 生駒祐介, 西牟田章戸, 鈴木哲也, 杉本伸二
- Industrial Property Rights Holder
  学校法人慶應義塾,株式会社ヤクルト本社
- Industrial Property Number
  2010-020457
- Filing Date
  2010
- Data Source
  KAKENHI-PROJECT-21590176
[Patent] 抗がん剤の感受性の判定方法2010
- Inventor(s)
  谷川原祐介、鈴木小夜、生駒祐介, 西牟田章戸、鈴木哲也、杉本伸二
- Industrial Property Rights Holder
  学校法人慶應義塾、株式会社ヤクルト本社
- Industrial Property Number
  2010-020457
- Filing Date
  2010-10-29
- Data Source
  KAKENHI-PROJECT-20390049
[Patent] 抗がん剤の感受性判定方法2010
- Inventor(s)
  谷川原祐介, 鈴木, 小夜, 入江秀大, 西牟田章戸, 鈴木哲也, 杉本伸二
- Industrial Property Rights Holder
  学校法人慶應義塾,株式会社ヤクルト本社
- Industrial Property Number
  2010-020456
- Filing Date
  2010
- Data Source
  KAKENHI-PROJECT-21590176
[Patent] 抗がん剤の感受性判定方法2010
- Inventor(s)
  谷川原祐介, 鈴木, 小夜, 入江秀大, 西牟田章戸, 鈴木哲也, 杉本伸二
- Industrial Property Rights Holder
  学校法人慶應義塾,株式会社ヤクルト本社
- Filing Date
  2010-10-29
- Overseas
- Data Source
  KAKENHI-PROJECT-21590176
[Patent] 抗がん剤の感受性判定方法2010
- Inventor(s)
  谷川原祐介、鈴木小夜、入江秀大,西牟田章戸、鈴木哲也、杉本伸二
- Industrial Property Rights Holder
  学校法人慶應義塾、株式会社ヤクルト本社
- Filing Date
  2010-10-29
- Overseas
- Data Source
  KAKENHI-PROJECT-21590176
[Patent] 抗がん剤の感受性判定方法2010
- Inventor(s)
  谷川原祐介, 鈴木小夜, 入江秀大, 西牟田章戸, 鈴木哲也, 杉本伸二
- Industrial Property Rights Holder
  学校法人慶應義塾株式会社ヤクルト本社
- Industrial Property Number
  2010-020456
- Filing Date
  2010
- Data Source
  KAKENHI-PROJECT-20390049
[Patent] 抗がん剤の感受性の判定方法2010
- Inventor(s)
  谷川原祐介, 鈴木小夜, 生駒祐介, 西牟田章戸, 鈴木哲也, 杉本伸二
- Industrial Property Rights Holder
  学校法人慶應義塾株式会社ヤクルト本社
- Industrial Property Number
  2010-020457
- Filing Date
  2010
- Data Source
  KAKENHI-PROJECT-20390049
[Patent] 抗がん剤の感受性判定方法2010
- Inventor(s)
  谷川原祐介、鈴木小夜、入江秀大, 西牟田章戸、鈴木哲也、杉本伸二
- Industrial Property Rights Holder
  学校法人慶應義塾、株式会社ヤクルト本社
- Industrial Property Number
  2010-020456
- Filing Date
  2010-10-29
- Data Source
  KAKENHI-PROJECT-20390049
[Patent] 抗がん剤の感受性の判定方法2010
- Inventor(s)
  谷川原祐介, 鈴木小夜, 生駒祐介, 西牟田章戸, 鈴木哲也, 杉本伸二
- Industrial Property Rights Holder
  学校法人慶應義塾,株式会社ヤクルト本社
- Filing Date
  2010-10-29
- Overseas
- Data Source
  KAKENHI-PROJECT-21590176
[Patent] 抗がん剤の感受性の判定方法2010
- Inventor(s)
  谷川原祐介, 鈴木小夜, 生駒祐介, 西牟田章戸, 鈴木哲也, 杉本伸二
- Industrial Property Rights Holder
  学校法人慶應義塾株式会社ヤクルト本社
- Filing Date
  2010-10-29
- Overseas
- Data Source
  KAKENHI-PROJECT-20390049
[Patent] 抗がん剤の感受性の判定方法2010
- Inventor(s)
  谷川原祐介、鈴木小夜、生駒祐介,西牟田章戸、鈴木哲也、杉本伸二
- Industrial Property Rights Holder
  学校法人慶應義塾、株式会社ヤクルト本社
- Filing Date
  2010-10-29
- Overseas
- Data Source
  KAKENHI-PROJECT-21590176
[Patent] 抗がん剤の感受性の判定方法2009
- Inventor(s)
  谷川原祐介, 鈴木小夜, 生駒祐介, 西牟田章戸, 鈴木哲也, 杉本伸二
- Industrial Property Rights Holder
  学校法人慶應義塾株式会社ヤクルト本社
- Industrial Property Number
  2010-020457
- Filing Date
  2009
- Data Source
  KAKENHI-PROJECT-20014025
[Patent] 抗がん剤の感受性判定方法2009
- Inventor(s)
  谷川原祐介, 鈴木小夜, 入江秀大, 西牟田章戸, 鈴木哲也, 杉本伸二
- Industrial Property Rights Holder
  学校法人慶應義塾株式会社ヤクルト本社
- Industrial Property Number
  2010-020456
- Filing Date
  2009
- Data Source
  KAKENHI-PROJECT-20014025
[Patent] 抗がん剤感受性の判定方法2009
- Inventor(s)
  谷川原祐介鈴木小夜杉本伸二
- Industrial Property Rights Holder
  学校法人慶應義塾, 株式会社ヤクルト本社
- Industrial Property Number
  2008-223384
- Filing Date
  2009-01-30
- Data Source
  KAKENHI-PROJECT-20390049
[Patent] 抗がん剤感受性判定マーカー2009
- Inventor(s)
  谷川原祐介, 渡辺光博, 有田恵理, 西牟田章戸, 山吉康子, 松崎健, 杉本伸二
- Industrial Property Rights Holder
  学校法人慶應義塾株式会社ヤクルト本社
- Filing Date
  2009-01-30
- Data Source
  KAKENHI-PROJECT-20014025
[Patent] 抗がん剤感受性の判定方法2009
- Inventor(s)
  谷川原祐介、鈴木小夜、杉本伸二
- Industrial Property Rights Holder
  学校法人慶應義塾、株式会社ヤクルト本社
- Industrial Property Number
  2008-223384
- Filing Date
  2009-01-30
- Data Source
  KAKENHI-PROJECT-20390049
[Patent] 抗がん剤の感受性判定マーカー2009
- Inventor(s)
  谷川原祐介, 鈴木哲也, 西牟田章戸, 杉本伸二
- Industrial Property Rights Holder
  学校法人慶應義塾株式会社ヤクルト本社
- Industrial Property Number
  2009-250258
- Filing Date
  2009-10-30
- Data Source
  KAKENHI-PROJECT-20014025
[Patent] 抗がん剤感受性の判定方法2008
- Inventor(s)
  谷川原祐介・鈴木小夜・杉本伸二
- Industrial Property Rights Holder
  学校法人慶應義塾、株式会社ヤクルト
- Industrial Property Number
  2008-021124
- Filing Date
  2008-01-31
- Data Source
  KAKENHI-PROJECT-19390255
[Patent] 抗がん剤感受性の判定方法2008
- Inventor(s)
  谷川原祐介鈴木小夜杉本伸二
- Industrial Property Rights Holder
  学校法人慶應義塾, 株式会社ヤクルト本社
- Industrial Property Number
  2008-223384
- Filing Date
  2008-09-01
- Overseas
- Data Source
  KAKENHI-PROJECT-20390049
[Patent] 抗がん剤感受性判定マーカー2008
- Inventor(s)
  谷川原祐介, 渡辺光博, 有田惠理, 西牟田章戸, 山吉康子, 松崎健, 杉本伸二
- Industrial Property Rights Holder
  学校法人慶應義塾株式会社ヤクルト本社
- Industrial Property Number
  2008-021123
- Filing Date
  2008-01-31
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-18390053
[Patent] 抗がん剤感受性の判定方法2008
- Inventor(s)
  谷川原祐介, 鈴木小夜, 杉本伸二
- Industrial Property Rights Holder
  学校法人慶應義塾株式会社ヤクルト本社
- Industrial Property Number
  2008-021124
- Filing Date
  2008-01-31
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-18390053
[Patent] 抗がん剤感受性判定マーカー2008
- Inventor(s)
  谷川原祐介・渡辺光博・有田惠理・西牟田章戸・山吉康子・松崎健・杉本伸二
- Industrial Property Rights Holder
  学校法人慶應義塾、株式会社ヤクルト
- Industrial Property Number
  2008-021123
- Filing Date
  2008-01-31
- Data Source
  KAKENHI-PROJECT-19390255
[Patent] 遺伝子マーカー及びその利用2006
- Inventor(s)
  谷川原祐介, 三原潔, 他
- Industrial Property Rights Holder
  学校法人慶應義塾大学
- Filing Date
  2006-01-13
- Data Source
  KAKENHI-PROJECT-16590121
[Patent] 遺伝子マーカー及びその利用2006
- Inventor(s)
  谷川原祐介, 三原潔, 他
- Industrial Property Rights Holder
  慶應義塾
- Filing Date
  2006-01-13
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-16590121
[Patent] 遺伝子マーカー及びその利用2005
- Inventor(s)
  谷川原祐介, 三原潔, 他
- Industrial Property Rights Holder
  学校法人慶應義塾大学
- Filing Date
  2005-05-30
- Data Source
  KAKENHI-PROJECT-16590121
[Patent] 遺伝子マーカー及びその利用2005
- Inventor(s)
  谷川原祐介, 三原潔, 他
- Industrial Property Rights Holder
  学校法人慶應義塾
- Industrial Property Number
  2005-006727
- Filing Date
  2005-01-13
- Data Source
  KAKENHI-PROJECT-16590121
[Patent] 遺伝子マーカー及びその利用2005
- Inventor(s)
  谷川原祐介, 三原潔, 他
- Industrial Property Rights Holder
  学校法人慶應義塾
- Industrial Property Number
  2005-006728
- Filing Date
  2005-01-13
- Data Source
  KAKENHI-PROJECT-16590121
[Patent] 遺伝子マーカー及びその利用2005
- Inventor(s)
  谷川原祐介, 三原潔, 他
- Industrial Property Rights Holder
  学校法人慶應義塾
- Filing Date
  2005-05-30
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-16590121
[Patent] 遺伝子マーカー及びその利用2004
- Inventor(s)
  谷川原祐介, 他
- Industrial Property Rights Holder
  学校法人慶應義塾
- Industrial Property Number
  2004-165013
- Filing Date
  2004-06-02
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-14370787
[Patent] 診断マーカー及び薬効マーカー、並びにそれらの利用方法2004
- Inventor(s)
  谷川原祐介, 他
- Industrial Property Rights Holder
  学校法人慶應義塾
- Industrial Property Number
  2004-368375
- Filing Date
  2004-12-20
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-14370787
[Patent] 抗がん剤の感受性の判定方法
- Inventor(s)
  谷川原祐介, 鈴木小夜, 生駒祐介, 西牟田章戸, 鈴木哲也, 杉本伸二
- Industrial Property Rights Holder
  学校法人慶應義塾株式会社ヤクルト本社
- Industrial Property Number
  2010-020457
- Data Source
  KAKENHI-PROJECT-20390049
[Patent] 抗がん剤の感受性の判定方法
- Inventor(s)
  谷川原祐介, 鈴木小夜, 生駒祐介, 西牟田章戸, 鈴木哲也, 杉本伸二
- Industrial Property Rights Holder
  学校法人慶應義塾株式会社ヤクルト本社
- Industrial Property Number
  2010-020457
- Data Source
  KAKENHI-PROJECT-21590176
[Presentation] Prospective evaluation of a developed S-1 dosage formula based on renal function.2019
- Author(s)
  Mizukami T, Takeuchi M, Imamura CK, Booka E, Takeuchi H, Kawakami T, Funakoshi T, Wakuda K, Aoki Y, Hamamoto Y, Kitago M, Kawakubo H, Boku N, Tanigawara Y, Kitagawa Y
- Organizer
  ASCO Gastrointestinal Cancers Symposium
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K08961
[Presentation] Exposure-response analysis of S-1 in patients with advanced gastric cancer.2019
- Author(s)
  Takeuchi M, Imamura CK, Booka E, Kasai H, Kawakubo H, Boku N, Tanigawara Y, Kitagawa Y.
- Organizer
  第17回日本臨床腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-17K08961
[Presentation] 腎機能に基づくS-1用量算出式「B-B formula」の検証試験2019
- Author(s)
  竹内優志，今村知世，坊岡英祐，竹内裕也，水上拓郎，川上武志，浜本康夫，川久保博文，朴成和，谷川原祐介，北川雄光
- Organizer
  第52回制癌剤適応研究会
- Data Source
  KAKENHI-PROJECT-17K08961
[Presentation] Prospective evaluation of the relationship between erlotinib concentration and efficacy in patients with non-small cell lung cancer harboring EGFR-activating mutations.2017
- Author(s)
  Hirotsugu Kenmotsu, Chiyo K. Imamura, Takahisa Kawamura, Takuya Oyakawa, Shota Omori, Kazuhisa Nakashima, Kazushige Wakuda, Akira Ono, Tetsuhiko Taira, Tateaki Naito, Haruyasu Murakami, Nobuyuki Yamamoto, Toshiaki Takahashi and Yusuke Tanigawara
- Organizer
  ESMO 2017 Congress
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K09568
[Presentation] TDM のサイエンスとプラクティス2013
- Author(s)
  谷川原祐介
- Organizer
  第30回日本TDM 学会・学術大会
- Place of Presentation
  熊本
- Year and Date
  2013-05-26
- Data Source
  KAKENHI-PROJECT-23390037
[Presentation] Pharmacogenomics-based personalized dosing of tamoxifen : Solution for controversy2013
- Author(s)
  Tanigawara Y
- Organizer
  第72回日本癌学会学術総会
- Place of Presentation
  横浜
- Year and Date
  2013-10-04
- Invited
- Data Source
  KAKENHI-PROJECT-23390037
[Presentation] ヒト膵臓細胞におけるゲムシタビン耐性のメタボローム解析2013
- Author(s)
  森本洋輔, 西弘二, 川島知憲, 谷川原祐介
- Organizer
  第72回日本癌学会学術総会
- Place of Presentation
  横浜
- Year and Date
  2013-10-03
- Data Source
  KAKENHI-PROJECT-23390037
[Presentation] ヒト大腸がん細胞における5-FU 耐性のメタボローム解析2013
- Author(s)
  藤原裕, 西牟田章戸, 川島知憲, 谷川原祐介
- Organizer
  第72回日本癌学会学術総会
- Place of Presentation
  横浜
- Year and Date
  2013-10-03
- Data Source
  KAKENHI-PROJECT-23390037
[Presentation] がん薬物療法の個別化に向けたPK/PD と統合オミックス研究2013
- Author(s)
  谷川原祐介
- Organizer
  第50回薬剤学懇談会研究討論会
- Place of Presentation
  札幌
- Year and Date
  2013-06-26
- Data Source
  KAKENHI-PROJECT-23390037
[Presentation] Cancer biomarkers in diagnostics and pharmacotherapy2013
- Author(s)
  Tanigawara Y
- Organizer
  FIP (International Pharmaceutical Federation)
- Place of Presentation
  Dublin, Ireland
- Year and Date
  2013-09-03
- Invited
- Data Source
  KAKENHI-PROJECT-23390037
[Presentation] Pharmaco-metabolomics for anticancer drugs2012
- Author(s)
  Tanigawara Y
- Organizer
  第10回日本臨床腫瘍学会学術集会
- Place of Presentation
  大阪
- Year and Date
  2012-07-26
- Data Source
  KAKENHI-PROJECT-23390037
[Presentation] シンポジウム「がん領域における薬剤師の能力向上」2012
- Author(s)
  谷川原祐介
- Organizer
  第33回日本病院薬剤師会近畿学術大会
- Place of Presentation
  ATCホール(大阪府)(招待講演)
- Year and Date
  2012-01-21
- Data Source
  KAKENHI-PROJECT-23390037
[Presentation] メタボローム解析によるヒト大腸癌細胞の5-FU+オキサリプラチンに対する応答機構の解明2012
- Author(s)
  津崎盾哉, 西牟田章戸, 谷川原祐介
- Organizer
  第10回日本臨床腫瘍学会学術集会
- Place of Presentation
  大阪
- Year and Date
  2012-07-27
- Data Source
  KAKENHI-PROJECT-23390037
[Presentation] Pharmaco-metabolomics of anticancer drugs2012
- Author(s)
  Tanigawara Y
- Organizer
  10th International Conference of the Asian Clinical Oncology Society
- Place of Presentation
  Seoul, Korea
- Year and Date
  2012-06-14
- Data Source
  KAKENHI-PROJECT-23390037
[Presentation] 我が国におけるバイオマーカー研究の現状：Pharmaco-metabolomics for anticancer drugs2012
- Author(s)
  谷川原祐介
- Organizer
  第10回日本臨床腫瘍学会学術集会
- Place of Presentation
  大阪
- Invited
- Data Source
  KAKENHI-PROJECT-23390037
[Presentation] Pharmaco-metabolomics of anticancer drugs2012
- Author(s)
  Y. Tanigawara
- Organizer
  10th International Conference of the Asian Clinical Oncology Society
- Place of Presentation
  Seoul (Korea)
- Invited
- Data Source
  KAKENHI-PROJECT-23390037
[Presentation] メロペネム高用量投与の可能性1.メロペネム3g投与におけるPK/PD2011
- Author(s)
  谷川原祐介
- Organizer
  第59回日本化学療法学会総会
- Place of Presentation
  札幌コンベンションセンター(北海道)(招待講演)
- Year and Date
  2011-06-25
- Data Source
  KAKENHI-PROJECT-23390037
[Presentation] Presidential Symposium 3 "Mega-clinical trial in Pan-Asia-Towards the golden standard therapy in Asia-", SPS3-3 "Pharmacogenomics"2011
- Author(s)
  Yusuke Tanigawara
- Organizer
  49th Annual Meeting of Japan Society of Clinical Oncology
- Place of Presentation
  Nagoya Congress Center, Aichi, Japan(招待講演)
- Year and Date
  2011-10-28
- Data Source
  KAKENHI-PROJECT-23390037
[Presentation] シンポジウム「がん薬物療法の薬学的ケア」2011
- Author(s)
  谷川原祐介
- Organizer
  医療薬学フォーラム2011
- Place of Presentation
  旭川市民文化会館(北海道)(招待講演)
- Year and Date
  2011-07-09
- Data Source
  KAKENHI-PROJECT-23390037
[Presentation] Cancer metabolomics by MS technology2011
- Author(s)
  Tanigawara Y
- Organizer
  12th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology (Plenary Lecture)
- Place of Presentation
  Stuttgart, Germany
- Year and Date
  2011-11-06
- Data Source
  KAKENHI-PROJECT-23390037
[Presentation] シンポジウム「がん専門薬剤師による薬学的介入・薬剤管理指導の実際」2011
- Author(s)
  谷川原祐介
- Organizer
  第21回日本医療薬学会年会
- Place of Presentation
  神戸国際展示場(兵庫県)(招待講演)
- Year and Date
  2011-10-01
- Data Source
  KAKENHI-PROJECT-23390037
[Presentation] シンポジウム「母集団薬物動態解析を用いた薬物遺伝学」2011
- Author(s)
  谷川原祐介
- Organizer
  第32回日本臨床薬理学会年会
- Place of Presentation
  アクトシティ浜松(静岡県)(招待講演)
- Year and Date
  2011-12-01
- Data Source
  KAKENHI-PROJECT-23390037
[Presentation] Pharmacogenomics2011
- Author(s)
  Tanigawara Y
- Organizer
  第49回日本癌治療学会学術集会
- Place of Presentation
  名古屋
- Year and Date
  2011-11-28
- Invited
- Data Source
  KAKENHI-PROJECT-23390037
[Presentation] Plenary Lecture "Cancer metabolomics by MS technology"2011
- Author(s)
  Yusuke Tanigawara
- Organizer
  12th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology
- Place of Presentation
  Stuttgart, Germany(招待講演)
- Year and Date
  2011-10-06
- Data Source
  KAKENHI-PROJECT-23390037
[Presentation] 基調講演「クリニカル・クエスチョンから臨床研究へ」2011
- Author(s)
  谷川原祐介
- Organizer
  日本病院薬剤師会東海ブロック・日本薬学会東海支部合同学術大会2011
- Place of Presentation
  ウインク愛知(愛知県)(招待講演)
- Year and Date
  2011-11-23
- Data Source
  KAKENHI-PROJECT-23390037
[Presentation] International Session "Pharmacogenomics", IS-6 "Post-genome proteomicand metabolomic analyses for pharmacological responses to anticancer agents"2011
- Author(s)
  Yusuke Tanigawara
- Organizer
  49th Annual Meeting of Japan Society of Clinical Oncology
- Place of Presentation
  Nagoya Congress Center, Aichi, Japan(招待講演)
- Year and Date
  2011-10-27
- Data Source
  KAKENHI-PROJECT-23390037
[Presentation] シンポジウム「Current status of PGx applications in medical practice」2011
- Author(s)
  谷川原祐介
- Organizer
  日本薬物動態学会第26回年会
- Place of Presentation
  広島国際会議場(広島県)(招待講演)
- Year and Date
  2011-11-18
- Data Source
  KAKENHI-PROJECT-23390037
[Presentation] メタボローム解析による大腸癌細胞のオキサリプラチン感受性因子の探索2011
- Author(s)
  大谷勇紀, 西牟田章戸, 谷川原祐介
- Organizer
  第9回日本臨床腫瘍学会学術集会
- Place of Presentation
  横浜
- Year and Date
  2011-07-21
- Data Source
  KAKENHI-PROJECT-23390037
[Presentation] Post-genome proteomic and metabolomic analyses for pharmacological responses to anticancer agents2011
- Author(s)
  Tanigawara Y
- Organizer
  第49回日本癌治療学会学術集会
- Place of Presentation
  名古屋
- Year and Date
  2011-11-27
- Invited
- Data Source
  KAKENHI-PROJECT-23390037
[Presentation] Metabolomic and Proteomic Analyses for Pharmacotherapy2010
- Author(s)
  Yusuke Tanigawara
- Organizer
  Annual Congress of International Pharmaceutical Federation (FIP 2010)
- Place of Presentation
  Lisbon, Portugal
- Year and Date
  2010-08-30
- Data Source
  KAKENHI-PROJECT-20390049
[Presentation] 大腸癌細胞におけるS100A10のオキサリプラチン感受性予測タンパク質としての特異性2010
- Author(s)
  鈴木小夜, 西牟田章戸, 谷川原祐介
- Organizer
  日本薬学会第130年会
- Place of Presentation
  岡山
- Year and Date
  2010-03-28
- Data Source
  KAKENHI-PROJECT-21590176
[Presentation] Protein S100A10, Expression and correlation with sensitivity to oxaliplatin in colorectal cancer cells2010
- Author(s)
  鈴木小夜, 谷川原祐介, 他
- Organizer
  American Association for Cancer Research Annual Meeting 2010
- Place of Presentation
  Washington DC, USA
- Year and Date
  2010-04-20
- Data Source
  KAKENHI-PROJECT-20390049
[Presentation] CE-TOFMS metabolome analysis for pharmacological response to CPT-11 in colorectal cancer cells with different ehemosensitivities2010
- Author(s)
  西牟田章戸, 谷川原祐介, 他
- Organizer
  American Association for Cancer Research Annual Meeting 2010
- Place of Presentation
  Washington DC, USA
- Year and Date
  2010-04-19
- Data Source
  KAKENHI-PROJECT-20390049
[Presentation] Cancer Pharmacogenomics in Asia : Post-genome proteomic and metabolomic analysis for pharmacological responses to anticancer agents2010
- Author(s)
  Yusuke Tanigawara
- Organizer
  9th International Conference of the Asian Clinical Oncology Society
- Place of Presentation
  Gifu(Japan)
- Year and Date
  2010-08-25
- Data Source
  KAKENHI-PROJECT-21590176
[Presentation] メタボロミクスによる大腸癌のイリノテカン感受性予測バイオマーカーの探索2010
- Author(s)
  西牟田章戸, 谷川原祐介, 他
- Organizer
  第69回日本癌学会学術集会
- Place of Presentation
  大阪国際コンベンションセンター(大阪府)
- Year and Date
  2010-09-24
- Data Source
  KAKENHI-PROJECT-20390049
[Presentation] Metabolomic and proteomic analyses for pharmacotherapy2010
- Author(s)
  Yusuke Tanigawara
- Organizer
  Annual Congress of International Pharmaceutical Federation(FIP 2010)
- Place of Presentation
  Lisbon(Portugal)
- Year and Date
  2010-08-30
- Data Source
  KAKENHI-PROJECT-21590176
[Presentation] Cancer Pharmacogenomics in Asia : Post-genome proteomic and metabolomic analysis for pharmacological responses to anticancer agents2010
- Author(s)
  Yusuke Tanigawara
- Organizer
  9th International Conference of the Asian Clinical Oncology Society
- Place of Presentation
  Gifu (Japan)
- Year and Date
  2010-08-25
- Data Source
  KAKENHI-PROJECT-20390049
[Presentation] オキサリプラチン/5-FU併用に対する大腸がん細胞応答のプロテオーム・メタボローム解析2010
- Author(s)
  生駒祐介, 鈴木哲也, 西牟田章戸, 鈴木小夜, 谷川原祐介
- Organizer
  第8回日本臨床腫瘍学会学術集会
- Place of Presentation
  東京
- Year and Date
  2010-03-18
- Data Source
  KAKENHI-PROJECT-21590176
[Presentation] Metabolomic and proteomic analyses for pharmacotherapy2010
- Author(s)
  Yusuke Tanigawara
- Organizer
  Annual Congress of International Pharmaceutical Federation (FIP 2010)
- Place of Presentation
  Lisbon (Portugal)
- Year and Date
  2010-08-30
- Data Source
  KAKENHI-PROJECT-20390049
[Presentation] Cancer Pharmacogenomics in Asia : Post-genome Proteomic and Metabolic Analysis for Pharmacological Responses to Anticancer Agents2010
- Author(s)
  谷川原祐介
- Organizer
  9th International Conference of the Asian Clinical Oncology Society
- Place of Presentation
  Gifu, Japan
- Year and Date
  2010-08-25
- Data Source
  KAKENHI-PROJECT-20390049
[Presentation] SN-38/5-FU併用に対する大腸癌細胞応答のプロテオーム・メタボローム解析2010
- Author(s)
  入江秀大, 鈴木哲也, 西牟田章戸, 鈴木小夜, 谷川原祐介
- Organizer
  第8回日本臨床腫瘍学会学術集会
- Place of Presentation
  東京
- Year and Date
  2010-03-18
- Data Source
  KAKENHI-PROJECT-21590176
[Presentation] Protein S100A10 : Expression and correlation with sensitivity to oxaliplatin in colorectal cancer cells2010
- Author(s)
  Sayo Suzuki, Akito Nishimuta, Yusuke Tanigawara
- Organizer
  American Association for Cancer Research Annual Meeting 2010
- Place of Presentation
  Washington, DC(USA)
- Year and Date
  2010-04-20
- Data Source
  KAKENHI-PROJECT-21590176
[Presentation] Pharmaco-proteomics and metabolomics for personalized medicine2009
- Author(s)
  Yusuke Tanigawara
- Organizer
  International Conference of FIP and JSPHCS
- Place of Presentation
  Nagasaki Brick Hall (Nagasaki)
- Year and Date
  2009-10-25
- Data Source
  KAKENHI-PROJECT-20014025
[Presentation] プロテオーム/メタボロームによる抗がん剤反応性バイオマーカー研究2009
- Author(s)
  谷川原祐介
- Organizer
  第47回日本癌治療学会学術集会シンポジウム
- Place of Presentation
  パシフィコ横浜(横浜市)
- Year and Date
  2009-10-24
- Data Source
  KAKENHI-PROJECT-20390049
[Presentation] Pharmaco-proteomics and metabolomics for personalized medicine2009
- Author(s)
  谷川原祐介
- Organizer
  International Conference Supported by FIP and JSPHCS
- Place of Presentation
  Nagasaki Brick Hall(Nagasaki)
- Year and Date
  2009-10-25
- Data Source
  KAKENHI-PROJECT-21590176
[Presentation] プロテオーム解析によるオキサリプラチン感受性予測バイオマーカーの同定2009
- Author(s)
  鈴木小夜, 山吉康子, 西牟田章戸, 谷川原祐介
- Organizer
  第68回日本癌学会学術総会
- Place of Presentation
  横浜
- Year and Date
  2009-10-03
- Data Source
  KAKENHI-PROJECT-21590176
[Presentation] Pharmaco-proteomics and metabolomics for personalized medicicine, Approach of individualized medicine in near-future2009
- Author(s)
  Yusuke Tanigawara
- Organizer
  FIP and JSPHCS International Conference on Individualized Medicine : Bridging between Scientific and Clinical Studies
- Place of Presentation
  Nagasaki(Japan)
- Year and Date
  2009-10-25
- Data Source
  KAKENHI-PROJECT-21590176
[Presentation] プロテオーム/メタボロームによる抗がん剤反応性バイオマーカー2009
- Author(s)
  谷川原祐介, 西牟田章戸, 鈴木小夜
- Organizer
  第47回日本癌治療学会学術集会
- Place of Presentation
  横浜
- Year and Date
  2009-10-24
- Data Source
  KAKENHI-PROJECT-21590176
[Presentation] Pharmaco-proteomics and metabolomics for personalized medicine2009
- Author(s)
  谷川原祐介
- Organizer
  International Conference of FIP and JSPHCS
- Place of Presentation
  Nagasaki Brick Hall(Nagasaki)
- Year and Date
  2009-10-25
- Data Source
  KAKENHI-PROJECT-20390049
[Presentation] Pharmacoproteomics and metabolomics for personalized medicicine, Approach of individualized medicine in near-future2009
- Author(s)
  Yusuke Tanigawara
- Organizer
  FIP and JSPHCS International Conference on Individualized Medicine : Bridging between Scientific and Clinical Studies
- Place of Presentation
  Nagasaki (Japan)
- Year and Date
  2009-10-25
- Data Source
  KAKENHI-PROJECT-20390049
[Presentation] S100A10 as a potential protein biomarker for oxaliplatin sensitivity in colorectal cancer cells2009
- Author(s)
  Sayo Suzuki, Yasuko Yamayoshi, Akito Nishimuta, Mitsuhiro Watanabe, Yusuke Tanigawara
- Organizer
  American Association for Cancer Research Annual Meeting 2009
- Place of Presentation
  Denver(USA)
- Year and Date
  2009-04-20
- Data Source
  KAKENHI-PROJECT-21590176
[Presentation] プロテオーム/メタボロームによる抗がん剤反応性バイオマーカー研究2009
- Author(s)
  谷川原祐介
- Organizer
  第47回日本癌治療学会学術集会シンポジウム
- Place of Presentation
  パシフィコ横浜(横浜市)
- Year and Date
  2009-10-24
- Data Source
  KAKENHI-PROJECT-21590176
[Presentation] プロテオーム/メタボロームによる抗がん剤反応性バイオマーカー研究2009
- Author(s)
  谷川原祐介
- Organizer
  第47回日本癌治療学会学術集会シンポジウム
- Place of Presentation
  パシフィコ横浜(横浜市)
- Year and Date
  2009-10-24
- Data Source
  KAKENHI-PROJECT-20014025
[Presentation] New biomarkers for acute rejection and therapeutic effect of immunosuppressive drugs in organ transplantation.2006
- Author(s)
  Mihara K, iketani O, Tanigawara Y
- Organizer
  The 3rd Korea-Japan Joint Symposium on Drug Delivery and Therapy
- Place of Presentation
  Seoul.
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18590155
[Presentation] Expression of AIF1, a gene marker for rejection, in peripheral blood in rat transplantation model and living-donor Liver transplantation.2006
- Author(s)
  Ishikawa H, Mihara K, Tanigawara Y, et. al.
- Organizer
  The 23rd Annual Meeting of The Japanese Society of Therapeutic Drug Monitoring
- Place of Presentation
  Tokyo
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18590155
[Presentation] New biomarkers for acute rejection and therapeutic effect of immunosu ppressive drugs in organ transplantation2006
- Author(s)
  Mihara K, Iketani O, Tanigawara Y
- Organizer
  The 3rd Korea-Japan Joint Symposium on Drug Delivery and Therapy
- Place of Presentation
  韓国、ソウル
- Year and Date
  2006-04-21
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-18590155
[Presentation] ヒト膵癌細胞におけるゲムシタビン耐性のメタボローム解析
- Author(s)
  森本洋輔、西　弘二、川島知憲、谷川原祐介
- Organizer
  第72回日本癌学会学術総会
- Place of Presentation
  横浜
- Data Source
  KAKENHI-PROJECT-23390037
[Presentation] 医療からみた創薬・治療薬開発研究のイノベーション：クリニカル・クエスチョンから臨床研究へ：タモキシフェンの薬理遺伝学的研究
- Author(s)
  谷川原祐介
- Organizer
  日本薬学会第134年会
- Place of Presentation
  熊本
- Invited
- Data Source
  KAKENHI-PROJECT-23390037
[Presentation] 特別講演「TDMのサイエンスとプラクティス」
- Author(s)
  谷川原祐介
- Organizer
  第30回日本TDM学会・学術大会
- Place of Presentation
  熊本
- Invited
- Data Source
  KAKENHI-PROJECT-23390037
[Presentation] Pharmacogenomics-based personalized dosing of tamoxifen: Solution for controversy
- Author(s)
  Yusuke Tanigawara
- Organizer
  第72回日本癌学会学術総会
- Place of Presentation
  横浜
- Invited
- Data Source
  KAKENHI-PROJECT-23390037
[Presentation] 患者に優しい化学療法
- Author(s)
  谷川原祐介
- Organizer
  日本薬剤学会第28年会
- Place of Presentation
  愛知
- Invited
- Data Source
  KAKENHI-PROJECT-23390037
[Presentation] 抗がん剤の薬理学
- Author(s)
  谷川原祐介
- Organizer
  第51回日本癌治療学会学術集会
- Place of Presentation
  京都
- Invited
- Data Source
  KAKENHI-PROJECT-23390037
[Presentation] ヒト大腸がん細胞における5-FU耐性のメタボローム解析
- Author(s)
  藤原　裕、西牟田章戸、川島知憲、谷川原祐介
- Organizer
  第72回日本癌学会学術総会
- Place of Presentation
  横浜
- Data Source
  KAKENHI-PROJECT-23390037
[Presentation] Cancer biomarkers in diagnostics and pharamacotherapy
- Author(s)
  Yusuke Tanigawara
- Organizer
  FIP (International Pharmaceutical Federation)
- Place of Presentation
  Dublin, Ireland
- Invited
- Data Source
  KAKENHI-PROJECT-23390037
[Presentation] がん薬物療法の個別化に向けたPK/PDと統合オミックス研究
- Author(s)
  谷川原祐介
- Organizer
  第50回薬剤学懇談会研究討論会
- Place of Presentation
  札幌
- Invited
- Data Source
  KAKENHI-PROJECT-23390037

1. MORITA Kunihiko (80327717)

# of Collaborated Projects: 6 results

# of Collaborated Products: 0 results
2. OKUMURA Katsuhiko (60025707)

# of Collaborated Projects: 6 results

# of Collaborated Products: 0 results
3. UEDA Kazumitsu (10151789)

# of Collaborated Projects: 5 results

# of Collaborated Products: 0 results
4. HORI Ryohei (40001036)

# of Collaborated Projects: 5 results

# of Collaborated Products: 0 results
5. HIRAI Midori (70228766)

# of Collaborated Projects: 4 results

# of Collaborated Products: 0 results
6. KIOKA Noriyuki (90234179)

# of Collaborated Projects: 3 results

# of Collaborated Products: 0 results
7. KOMANO Tohru (30026413)

# of Collaborated Projects: 3 results

# of Collaborated Products: 0 results
8. WATANABE Mitsuhiro (10450842)

# of Collaborated Projects: 3 results

# of Collaborated Products: 0 results
9. SUZUKI Sayo (90424134)

# of Collaborated Projects: 3 results

# of Collaborated Products: 8 results
10. IMAMURA Chiyo (00570954)

# of Collaborated Projects: 3 results

# of Collaborated Products: 5 results
11. YASUHARA Masato (00127151)

# of Collaborated Projects: 3 results

# of Collaborated Products: 0 results
12. KAMIYA Akira (90124792)

# of Collaborated Projects: 3 results

# of Collaborated Products: 0 results
13. ITOH Hiroshi (40252457)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
14. NISHIMUTA Akito (00424135)

# of Collaborated Projects: 2 results

# of Collaborated Products: 4 results
15. TANABE Minoru (50197513)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
16. MIHARA Kiyoshi (00281444)

# of Collaborated Projects: 2 results

# of Collaborated Products: 6 results
17. INUI Ken-ichi (70034030)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
18. 村田満 (50174305)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
19. WAKINO Shu (50265823)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
20. HOSODA Kiminori (40271598)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
21. SONE Masakatsu (40437207)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
22. MORIMOTO Kokichi (10468506)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
23. SUGIZAKI Taichi (00468480)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
24. HIRASAWA Akira (90296658)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
25. NISHI Koji (00398249)

# of Collaborated Projects: 1 results

# of Collaborated Products: 11 results
26. HE Yan-ling (70233640)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
27. TAKANO Mikihisa (20211336)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
28. KOBAYASHI Yoshio (80118950)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
29. SHIMAZU Motohide (70124948)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
30. KONDO Keiichi (20332827)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
31. HAMADA Akinobu (00322313)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
32. NAKAJIMA Masamitsu (20198097)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
33. ASANO Koichiro (60192944)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
34. IWAKAWA Seigo (50168548)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
35. SAKURAI Tunetaro (80127084)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
36. Hirotsugu Kenmotsu (50602637)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
37. 筧善行 (20214273)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
38. 福本学 (60156809)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
39. 桑野信彦 (80037431)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
40. 大野竜三 (70093002)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
41. 富田章弘 (40251483)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
42. 石田良司 (50150214)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
43. 秋山伸一 (60117413)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
44. 小川聡 (90124940)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
45. 山口佳寿博 (30129712)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
46. 角田達彦

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Tanigawara Yusuke 谷川原 祐介

谷川原 祐介 タニガワラ ユウスケ

TANIGAWARA Yusuke 谷川原 祐介

Research Projects

Research Products

Co-Researchers

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Proteomic and metabolomic analysis on chemo-sensitivity and resistance of cancer towards personalized medicinePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

がんのメタボローム解析に基づく抗がん剤反応性予測の新戦略Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Proteomic analysis for elucidation of individual differences in chemotherapeutic response and for biomarker developmentPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Proteomic approach for personalized Medicine in cancer chemotherapyPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

薬物代謝酵素の遺伝子変異多型と抗がん剤の薬理反応強度との相関解析Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Tanigawara Yusuke 谷川原祐介

谷川原祐介タニガワラユウスケ

TANIGAWARA Yusuke 谷川原祐介